Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,001)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07117279 | A Prospective Observational Cohort Study on Dynamic CD8+ T-cell Profiling and Multi-omics Biomarkers for Predicting Conversion Therapy Response in Unresectable Hepatocellular Carcinoma | not yet recruiting | — | 120 | Tongji HospitalOTHER | 0 | Aug 12, 2025 | clinicaltrials |
| NCT07118566 | Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases | not yet recruiting | Phase 2 | 40 | China Medical University, ChinaOTHER | 0 |
| Aug 12, 2025 |
| clinicaltrials |
| NCT07118735 | AHCC® as Immune Modulator in Cancer Patients Treated With Immunotherapy(NCKUH) | not yet recruiting | N/A | 94 | National Cheng-Kung University HospitalOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT07114666 | XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer | not yet recruiting | N/A | 12 | Peking Union Medical College HospitalOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT07115550 | A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab Injection Combined With Regorafenib in the Treatment of Advanced Second-line or Above Hepatocellular Carcinoma | not yet recruiting | N/A | 24 | Huai'an First People's HospitalOTHER | 0 | Aug 11, 2025 | clinicaltrials |
| NCT07026981 | [Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers | not yet recruiting | Early Phase 1 | 12 | Qiubai LiOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT07112833 | A Phase II Clinical Study of Induction Adebrelimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) | not yet recruiting | Phase 2 | 36 | Hebei Medical University Fourth HospitalOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT06196671 | Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer(PTCA199-8) | not yet recruiting | Phase 2 | 30 | Fudan UniversityOTHER | 0 | Aug 7, 2025 | clinicaltrials |
| NCT07108504 | Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer | not yet recruiting | Phase 2 | 30 | Shanghai Zhongshan HospitalOTHER | 0 | Aug 7, 2025 | clinicaltrials |
| NCT07100236 | 29-Gene Liver Cancer Subtype and Immunotherapy Effectiveness | not yet recruiting | — | 350 | Junjie XuOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT07025850 | Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer | not yet recruiting | Phase 1 / Phase 2 | 20 | Fudan UniversityOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT07098949 | Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery | not yet recruiting | N/A | 346 | Guangzhou University of Traditional Chinese MedicineOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT07099794 | A Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination Regimen | not yet recruiting | Phase 2 | 90 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT07099924 | Rectus Sheath Catheters Following Midline Laparotomy | not yet recruiting | N/A | 40 | Asklepios Kliniken Hamburg GmbHOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT07085273 | Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric Cancer | not yet recruiting | Phase 2 | 33 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 0 | Jul 31, 2025 | clinicaltrials |
| NCT07095309 | Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/ III Colorectal Cancer(NeoART-M) | not yet recruiting | Phase 2 | 120 | Metanoic Health Ltd.INDUSTRY | 1 | Jul 31, 2025 | clinicaltrials |
| NCT07096752 | Screening and Validation of Serum Protein Biomarkers for Early Diagnosis of Gastric Cancer | not yet recruiting | — | 1,200 | Shanghai Zhongshan HospitalOTHER | 0 | Jul 31, 2025 | clinicaltrials |
| NCT07097064 | Evaluation of the Stereotactic MR-guided Adaptive Radiotherapy for Locally Advanced Pancreatic Cancers(RAIPANC) | not yet recruiting | Phase 2 | 160 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT06839092 | Prophylactic PIPAC in Patients With High-risk Colorectal Cancer(PROPAC) | not yet recruiting | Phase 3 | 160 | Jeremy MeyerOTHER | 0 | Jul 30, 2025 | clinicaltrials |
| NCT07093593 | Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs(RAMA) | not yet recruiting | N/A | 260 | Centre Georges Francois LeclercOTHER | 0 | Jul 30, 2025 | clinicaltrials |
| NCT07090304 | China Colorectal Cancer Screening Trial 2 (C-Cost2) | not yet recruiting | N/A | 7,504 | Zhejiang UniversityOTHER | 0 | Jul 29, 2025 | clinicaltrials |
| NCT07088133 | Clinical Trials of the Hepatitis B Sandwich Combination Therapy for Treating Patients Infected With Hepatitis B Virus | not yet recruiting | N/A | 12 | Shanghai Zhongshan HospitalOTHER | 0 | Jul 28, 2025 | clinicaltrials |
| NCT07088744 | Comparison of the Sensitivity of pCLE and Pathological Biopsy Before ESD | not yet recruiting | — | 169 | Changhai HospitalOTHER | 1 | Jul 28, 2025 | clinicaltrials |
| NCT07074353 | Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer(CinClare-2) | not yet recruiting | Phase 3 | 360 | Zhejiang Cancer HospitalOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT07080411 | the Efficacy of MR-guided Online Adaptive Radiotherapy for Locally Advanced Rectal Cancer | not yet recruiting | N/A | 49 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 0 | Jul 23, 2025 | clinicaltrials |
| NCT07077369 | WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical Therapy | not yet recruiting | Phase 1 | 10 | West China HospitalOTHER | 0 | Jul 22, 2025 | clinicaltrials |
| NCT07077798 | Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver Resection | not yet recruiting | N/A | 234 | Wan-Guang ZhangOTHER | 0 | Jul 22, 2025 | clinicaltrials |
| NCT07078292 | The Efficacy and Safety of First-line Treatment Combined With Immunotherapy for Advanced Hepatocellular Carcinoma: a Single Center, Real-world Study | not yet recruiting | — | 400 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Jul 22, 2025 | clinicaltrials |
| NCT07078305 | Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment | not yet recruiting | Phase 2 | 134 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Jul 22, 2025 | clinicaltrials |
| NCT07075419 | JDB153 Combined With Penpulimab for Hepatocellular Carcinoma After Standard Treatment Failure | not yet recruiting | Phase 1 / Phase 2 | 10 | West China HospitalOTHER | 0 | Jul 20, 2025 | clinicaltrials |
| NCT06541561 | Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Pancreatectomy | not yet recruiting | N/A | 132 | West China HospitalOTHER | 0 | Jul 17, 2025 | clinicaltrials |
| NCT07071844 | BETWEEN: Biweekly Bevacizumab + Trifluridine/Tipiracil to Reduce Grade 3-4 Neutropenia in mCRC Patients(BETWEEN) | not yet recruiting | Phase 2 | 162 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 17, 2025 | clinicaltrials |
| NCT07067359 | The Intensive Nutritional Support in Esophageal Cancer Undergoing Neoadjuvant Therapy(INSECNT) | not yet recruiting | N/A | 200 | Sichuan UniversityOTHER | 0 | Jul 16, 2025 | clinicaltrials |
| NCT07067450 | Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma | not yet recruiting | N/A | 98 | Sichuan UniversityOTHER | 0 | Jul 16, 2025 | clinicaltrials |
| NCT06710860 | ScreenTalk to Improve Colorectal Cancer Screening Uptake Among First-degree Relatives of Patients: a Study Protocol | not yet recruiting | N/A | 314 | Sun Yat-sen UniversityOTHER | 1 | Jul 15, 2025 | clinicaltrials |
| NCT07064655 | Non-gastric Conduit Reconstruction After Esophagectomy | not yet recruiting | — | 25 | Samsung Medical CenterOTHER | 0 | Jul 15, 2025 | clinicaltrials |
| NCT07064668 | Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study | not yet recruiting | Phase 2 | 300 | Tongji HospitalOTHER | 1 | Jul 15, 2025 | clinicaltrials |
| NCT07062328 | A Trial of Recaticimab and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable BTC(HP-BTC-002) | not yet recruiting | Phase 2 | 39 | Sun Yat-sen UniversityOTHER | 0 | Jul 14, 2025 | clinicaltrials |
| NCT07064447 | Spanish Registry of Direct Cholangiopancreatoscopy by Single Operator | not yet recruiting | — | 260 | Germans Trias i Pujol HospitalOTHER | 0 | Jul 14, 2025 | clinicaltrials |
| NCT07059949 | Short Course Radiotherapy Followed by CAPOX and Carrilizumab and Bevacizumab or Cetuximab for the Initial Treatment of Unresectable Metastatic Rectal Cancer(Union-mRC) | not yet recruiting | Phase 2 | 80 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 0 | Jul 11, 2025 | clinicaltrials |
| NCT07058649 | Downstaging Prediction Model for HCC | not yet recruiting | — | 369 | Beijing Tsinghua Chang Gung HospitalOTHER | 0 | Jul 10, 2025 | clinicaltrials |
| NCT07059338 | Dual EGFR/HER2 Blockade Combined With Irinotecan for the Treatment of HER2-Positive Metastatic Colorectal Cancer(HERBIC) | not yet recruiting | Phase 2 | 34 | Sun Yat-sen UniversityOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT07059442 | Screening for Anal Cancer and Precancer in Women With HIV (SANCA)(SANCA) | not yet recruiting | N/A | 1,000 | Karolinska InstitutetOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT07055568 | A Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Allogeneic iNKT Cell Infusion in Subjects With Advanced Pancreatic Cancer | not yet recruiting | N/A | 18 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Jul 9, 2025 | clinicaltrials |
| NCT07056270 | Development of a Set of Auxiliary Decision-making System for the Perioperative Period of Hepatectomy Based on Static CT and Artificial Intelligence. | not yet recruiting | — | 500 | Tongji HospitalOTHER | 0 | Jul 9, 2025 | clinicaltrials |
| NCT07056972 | Surveillance Discontinuation in 5 Year Stable Trivial Branch Duct Intraductal Papillary Mucinous Neoplasms(TRIVIAL) | not yet recruiting | — | 394 | Azienda Ospedaliera di PadovaOTHER | 0 | Jul 9, 2025 | clinicaltrials |
| NCT07055048 | The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/Contrast-enhanced MRI in Malignant Liver Lesions | not yet recruiting | — | 60 | Shanghai East HospitalOTHER | 0 | Jul 8, 2025 | clinicaltrials |
| NCT07051785 | Fruquintinib vs Bevacizumab Combined With Irinotecan Liposome and Capecitabine as Second-Line Therapy for Advanced Metastatic Colorectal Cancer(ARK) | not yet recruiting | Phase 2 | 68 | Liu HuangOTHER | 0 | Jul 4, 2025 | clinicaltrials |
| NCT07049185 | QL1706 Plus Celecoxib in Advanced Esophageal Squamous Cell Carcinoma(QICE-ESCC) | not yet recruiting | Phase 2 | 35 | Peking University Cancer Hospital & InstituteOTHER | 0 | Jul 3, 2025 | clinicaltrials |
| NCT07050524 | Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial | not yet recruiting | Phase 2 | 80 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jul 3, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Aug 12, 2025source: clinicaltrials